1 TUESDAY/WEDNESDAY EDITION TUESDAY 6:30 a.m. 4:30 p.m. Registration: STS 50th Annual Meeting Convention Center Entrance 7:00 a.m. 8:00 a.m. Early Riser Sessions Location printed on ticket Early Riser Health Policy Forum: Physicians Payment Sunshine Act Implementation What CT Surgeons Need to Know Grand Ballroom 4-6 8:15 a.m. 10:15 a.m. Adult Cardiac Session: General I Crystal Ballroom G-Q Adult Cardiac Session: Mitral Valve Grand Ballroom 7A Congenital Session: Pediatric Congenital II Grand Ballroom 4-6 General Thoracic Session: Esophageal Grand Ballroom 7B General Thoracic Session: Lung Cancer II Grand Ballroom 8A Patient Safety Symposium: Safely Adopting New Technology in Cardiothoracic Surgery Grand Ballroom 1-3 STS/EACTS: Repair of Type A Aortic Dissection Grand Ballroom 8B 9:00 a.m. 4:30 p.m. Scientific Posters Open Palms Ballroom Foyer Exhibits Open Cypress Ballroom 11:00 a.m. 12:30 p.m. Adult Cardiac Session: Aortic Valve Grand Ballroom 7A Adult Cardiac Session: General II Crystal Ballroom G-Q Basic Science Research: General Thoracic Grand Ballroom 1-3 Cardiothoracic Surgical Education Grand Ballroom 8B Clinical Trials: Reflections on Old and Plans for New Grand Ballroom 8A STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 ORLANDO, FLORIDA Continued on page 3 David Fullerton Elected STS President D avid A. Fullerton, MD, of Denver, was elected by the membership yesterday evening as the Society s President. He will be the first to lead STS into its second half century. STS has been a preeminent medical society for many years, said Dr. Fullerton. It is truly a great honor to lead such a tremendous organization. Its influences span far beyond our own specialty, and I plan to continue that tradition during my tenure. Dr. Fullerton heads the Division of Cardiothoracic Surgery at the University of Colorado School of Medicine, where he is also a Professor of Surgery, holds the John T. M. Wright Endowed Chair in Heart Valve Surgery, and is the Director of Cardiothoracic Surgical Research and the Director of the University s Thoracic Surgery Residency Program. In addition, he is the Cardiac Surgeon-in-Chief and Co- Director of the Cardiothoracic Surgical Intensive Care Unit for the University of Colorado Hospital. Born in Texas, Dr. Fullerton received his undergraduate degree from Southern Methodist University. He graduated Magna Cum Laude from the University of Missouri School of Medicine, where he was a member of the national medical honor society Alpha Omega Alpha. After completing a residency in general surgery at the University of Washington, including 1 year of research in coronary physiology, he moved to the University of Colorado for a residency in thoracic surgery. Dr. Fullerton remained on the faculty at the University of Colorado for the next 6 years before being recruited to Northwestern University in Chicago as Chief of Cardiothoracic Surgery and Wood Urges Colleagues to Take It to the Limit I nspired by a 1970s song by the Eagles, STS President Douglas E. Wood, MD is urging all cardiothoracic surgeons to push new boundaries and adopt a leadership style that embodies the servant leader qualities of courage, collaboration, integrity, empathy, humility, and selflessness. During his Presidential Address on Monday morning, Dr. Wood said that changing times demand that the male-dominated profession transition from a masculine, autocratic leadership style to one that is less authoritarian and more feminine. He described how a zero-sum game where there is a winner DAVID A. FULLERTON, MD STS President Douglas E. Wood, MD and a loser does not work in a modern, collaborative world. In Continued on page 5 Director of the Thoracic Surgery Residency Program. After 7 years in Chicago, he was recruited to the University of Colorado in A longtime STS member and volunteer, Dr. Fullerton served most recently as First Vice President on the STS Board of Directors. In , he also chaired the Workforce on Critical Care and served on the Executive Committee, the Workforce on Thoracic Surgery Resident Issues, and the Workforce on Research Development. In addition, Dr. Fullerton has held prominent leadership positions in several other organizations, including The American Board of Thoracic Surgery, the American College of Surgeons, the Thoracic Surgery Foundation for Research and Education, and the Residency Review Committee-Thoracic Surgery. He is a past president of the Western Thoracic Surgical Association. He currently serves on the Board of Directors of CTSNet, Inc. as well as the Joint Council on Thoracic Continued on page 3 Distinguished Service Award Announced On Monday evening, Douglas J. Mathisen, MD was awarded a Distinguished Service Award by STS. The Distinguished Service Award, established in 1969, recognizes those who have made significant and farreaching contributions to the Society and the specialty. Dr. Mathisen exemplifies a career dedicated to selfless service and a commitment to leadership in cardiothoracic surgery that has made a positive impact on our specialty for more than three decades, said STS President Douglas E. Wood, MD. There is perhaps no person who is more respected or admired for his integrity, hard work, and dedication to Continued on page 10
2 Consider Mitral Therapies. Visit the Medtronic booth and consider our comprehensive solutions in replacement, repair and surgical ablation. Opportunity Find in Change UC EN Medtronic, Inc All Rights Reserved
3 STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 TUESDAY/WEDNESDAY ISSUE 3 Schedule continued from page 1 Congenital Session: Pediatric Congenital III Grand Ballroom 4-6 General Thoracic Session: Mediastinal/Pulmonary Grand Ballroom 7B STS Grand Ballroom Elected STS President Continued from page 1 Surgery Education, and is President of the Thoracic Surgery Directors Association. STS has always done a terrific job of bringing value to its membership, and I look forward to continuing that during my presidency, said Dr. Fullerton. I plan to build upon the Society s strengths the STS National Database and advocacy efforts and add value for our members and our specialty. Dr. Fullerton s interests include all facets of cardiothoracic surgery and critical care. His clinical practice has an emphasis on structural heart disease. He lives with his wife, Christine, in Denver. The couple has two sons. 12:30 p.m. 1:30 p.m. Ethics Debate: Another Surgeon s Error Must You Tell the Patient? Grand Ballroom 9-11 Residents Luncheon Vinoy & Sawgrass 1:30 p.m. 2:30 p.m. C. Walton Lillehei Lecture: Shaf Keshavjee Crystal Ballroom G-Q 3:15 p.m. 3:30 p.m. 50th Anniversary Tribute Crystal Ballroom G-Q 3:30 p.m. 3:45 p.m. Award Presentations Crystal Ballroom G-Q 3:45 p.m. 4:30 p.m. Hot Topics in Cardiothoracic Surgery Crystal Ballroom G-Q 4:30 p.m. 5:30 p.m. Thomas B. Ferguson Lecture: Bassem Youssef Crystal Ballroom G-Q WEDNESDAY 6:30 a.m. 9:30 a.m. Registration: STS University Convention Center Entrance and Grand Ballroom Foyer 7:00 a.m. 9:00 a.m. STS University Grand Ballroom 9:30 a.m. 11:30 a.m. STS University (courses repeated) Grand Ballroom Future STS Annual Meetings STS 51st Annual Meeting January 24 28, 2015 San Diego, California STS 52nd Annual Meeting January 23 27, 2016 Phoenix, Arizona Designed for life Patient Breakthroughs with the On-X Prosthetic Heart Valve 30-50% reduction in morbid events compared to older generation valves in multiple international clinical trials* Lowest thrombotic complications compared to older generation valves in a noncompliant population (0.2%/pt.yr. vs. up to 6.5%/pt.yr.)* Greater than 50% reduction in bleeding for patients in a reduced anticoagulation trial (PROACT) East Anderson Lane, Building B, Austin, Texas U.S.A. T : (512) F : (512) The future is bright for On-X valve recipients!!! *References available upon request at 1. Puskas JD on behalf of the PROACT Investigators. Reduced anticoagulation after mechanical valve replacement: Interim results from the PROACT randomized FDA IDE trial. Presented May 6, 2013 at the American Association of Thoracic Surgery Annual Meeting 2013 in Minneapolis Minnesota; org/2013/files/monday/ _auditorium_0745_07.45%20john%20d.%20puskas.mp4 On-X aortic and mitral valves are FDA approved. CAUTION: Federal law restricts this device to sale by or on the order of a physician. Refer to the Instructions for Use that accompany each valve for indications, contraindications, warning, precautions and possible complications. CAUTION: Investigational use of this device in the Prospective Randomized On-X Valve Anticoagulation Trial (PROACT) is limited by federal law to investigational sites. Booth 821 in the exhibition hall
4 4 TUESDAY/WEDNESDAY ISSUE STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 Attend Tuesday s Lillehei Lecture S haf Keshavjee, MD, MSc, FRCSC will deliver the C. Walton Lillehei Lecture on Tuesday, January 28, at 1:30 p.m. His talk is titled The Future of Transplantation: Personalized Medicine for the Organ. Dr. Keshavjee, an STS member since 1994, is the Director of the Toronto Lung Transplant Program, Surgeon-in-Chief and James Wallace McCutcheon Chair in Surgery at University Health Network in Toronto, and Professor in the Division of Thoracic Surgery and Institute of Biomaterials and Biomedical Engineering at the University of Toronto. He led the development of the Toronto XVIVO Perfusion System, which treats and improves high-risk donor lungs so they can be safely used for transplant. The XVIVO system can benefit the majority of transplant centers, which are currently able to use only 10% or less of the available lungs. The new technology can safely increase the number of organs available, according to Dr. Keshavjee, who presented early results on the XVIVO system at last year s STS/AATS Tech-Con. The Lillehei Lecture is named for C. Walton Lillehei, MD ( ), an innovator during an era of rapid change in cardiothoracic surgery. He is considered to be the father SHAF KESHAVJEE, MD, of open-heart surgery, MSC, FRCSC whose work transformed the management of many diseases. Presenters Meet the Media in STS Press Conferences The Society will host three press conferences on Tuesday highlighting some of the groundbreaking research being presented at the STS 50th Annual Meeting. The press conferences will take place in the San Antonio room from 10:00 a.m. to 11:30 a.m. The Association of Transcatheter Aortic Valve Replacement (TAVR) Availability, Surgical Aortic Valve Replacement Case Volume, and In-Hospital Mortality in the United States: A Report From the STS Adult Cardiac Surgery Database and the STS/ACC TVT Registry Speaker: J. Matthew Brennan, MD, MPH, Duke University Medical Center, Durham, N.C. Pediatric Recipient Survival Beyond 15 Post- Heart Transplant Years: A Single Center Experience Speaker: Hannah Copeland, MD, Loma Linda University, Calif. Detection of Early Lung Cancer Using Exhaled Breath Speaker: Michael Bousamra, MD, University of Louisville School of Medicine, Ky. Visit the 50th Anniversary Commemorative Displays Founder Members Recognized During this special anniversary meeting, take some time during breaks in the scientific program to walk around the convention center and check out the special displays set up to honor 50 years of STS history. STS Timeline This timeline shows important moments in the Society s history from the 1960s to the present. Location: Cypress Ballroom Presidential Banners See the influential cardiothoracic surgeon leaders who have served as the Society s President over 50 years. Location: Registration Area State Proclamations View official proclamations from the many US states congratulating STS on its 50th anniversary. Location: STS Pavilion Video Wall Watch leaders from medical organizations and others congratulate STS on 50 years. Location: STS Pavilion List of Founder Members See which prominent cardiothoracic surgeons were among the Society s Founder Members. Location: Cypress Ballroom Remarkable Surgeons STS President Douglas E. Wood, MD has identified a number of CT surgeons who are doing remarkable things outside the operating room. This display highlights their unique achievements. Location: Cypress Ballroom More than a dozen of the Society's Founder Members were honored on Monday morning for their role in helping to create STS. Attend Tuesday s Ethics Debate On Medical Errors There is a growing consensus that medical errors by an individual physician should be self-disclosed to patients and their families. However, there is still considerable controversy as to whether physicians have a moral and/or legal obligation to report errors that are made by other medical practitioners. Robert M. Sade, MD, Professor of Surgery at the Medical University of South Carolina, Charleston, will act as facilitator for this important debate. Taking the Pro position, that such errors should be reported, will be Susan D. Moffatt-Bruce, MD, PhD, Associate Professor of Thoracic Surgery at The Ohio State University, Wexler Medical Center, Columbus. Taking the Con position will be Chadrick E. Denlinger, MD, Assistant Professor of Surgery at the Medical University of South Carolina, Charleston. Ethics Debate: Another Surgeon s Error Must You Tell the Patient? TUESDAY, 12:30 p.m. - 1:30 p.m. Grand Ballroom 9-11
5 STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 TUESDAY/WEDNESDAY ISSUE 5 Presidential Address Continued from page 1 our environments of heart teams and multidisciplinary care, winning is plural, Dr. Wood said. Sustainable improvements depend on collaboration and agreement. Over the longer time horizon, we will see that the real winners are those that invoke the skills of sharing credit and consensus building in order to achieve shared success. He admitted that this new paradigm may be difficult for the hard-charging and high-achieving men that make up a majority of the specialty: We would all benefit from diminishing our ego and striving for modesty and kindness. Vulnerability can be our new strength. He also encouraged the promotion of women in the specialty. Demonstrate the excitement, innovation, and career value and satisfaction that we have as surgeons. Encourage them The real winners are those that invoke the skills of sharing credit and consensus building in order to achieve shared success. Douglas E. Wood, MD because that is how we will grow, that is how we will stay relevant in the 21st century, and that is how all of us, women and men alike, will learn from each other how to make a difference for our specialty and for the world, Dr. Wood said. He also used his Presidential Address to congratulate the cardiothoracic surgeons who are taking it to the limit outside of the operating room. He named several surgeons one who became the vice president of Guatemala, one who designed a health education program for elementary school kids, and another who served in the U.S. Armed Forces. Prior to his address, Dr. Wood paid tribute to those in the audience who served in the Armed Forces, from World War II to the ongoing conflicts in the Middle East. He thanked them for their service and commended them for their inspirational work. Don t Miss Tuesday s Ferguson Lecture Egyptian cardiothoracic surgeon and television host Bassem Youssef, MD will present the Thomas B. Ferguson Lecture on Tuesday, January 28, at 4:30 p.m. Dr. Youssef is a cardiothoracic surgeon who BASSEM YOUSSEF, MD hosts Al Bernameg (The Program), a satirical TV news show in Egypt. The press has compared him to US comedian Jon Stewart, host of The Daily Show. Al Bernameg was one of the most-watched programs in the Arab world until it was abruptly suspended in November; he will resume broadcasting Al Bernameg next month. In 2013, Dr. Youssef was hailed by Time magazine as one of the most influential people in the world. The Ferguson Lecture was established in 2000 to honor Thomas B. Ferguson, MD, a Past President of both STS and the American Association for Thoracic Surgery, and the Editor of The Annals of Thoracic Surgery from 1984 to Download the 2014 Mobile App Access the STS 50th Annual Meeting Mobile App for iphone/ipad by searching for ScholarOne in the Apple App Store or scanning the QR code on the right. After downloading the app, select STS from the list of available meetings. If you have a non-apple device, a mobile-optimized HTML5 website version of the app is available by visiting or scanning the QR code to the right. Aortic Valve Dr. Wood received a standing ovation at the conclusion of his address. Join the Conversation Online! Aware of the new guidelines for Endocarditis? Visit Booth #411 to learn more Like the STS Facebook page at societyofthoracicsurgeons and follow STS on Twitter for more information about Orlando and the Annual Meeting. If you tweet about the Annual Meeting, be sure to use the hashtag #STS2014. Your tweets may appear on the large video wall near the STS Pavilion. After the Annual Meeting is over, the STS Facebook and Twitter pages will continue to deliver news on future STS events and CME credit opportunities. Life Restoring Technologies All trademarks owned by CryoLife, Inc CryoLife, Inc. All rights reserved.
6 6 TUESDAY/WEDNESDAY ISSUE STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 New STS Members for 2014 Active Members Craig V. Adams Ridgeland, MS Turki B. Albacker Riyadh, Saudi Arabia Orazio L. Amabile Jr. Phoenix, AZ Richard J. Angelico Easton, PA John H. Arnold Cleveland, OH Amit Arora New York, NY Azmi W. Atiya Northridge, CA Brian T. Bethea Dallas, TX Steven C. Bharadwaj Saskatoon, Canada Bryan M. Burt Palo Alto, CA Hannan Chaugle Richland, WA Nyen V. Chong Tacomam, WA Michael I. Chow Sacramento, CA Michael A. Coady Stamford, CT Michael C. Coello Grosse Pointe Farms, MI Heather M. Currier Ft. Gordon, GA Cornelius A. Davis III Davenport, IA Mark R. Dylewski Palmetto Bay, FL Sitaram M. Emani Boston, MA Farhood Farjah Seattle, WA Paul A. Fedalen Dover, DE Edward R. Ferguson Jr. Gadsden, AL Adrian J. Finol-Hernandez The Villages, FL Fernando Fleischman La Canada, CA Jan D. Galla Haworth, NJ Karen A. Gersch Cincinnati, OH Ravi K. Ghanta Charlottesville, VA Drew P. Greeley Neptune, NJ Mazen M. Hashisho Northport, NY Mohammed Hassan Albuquerque, NM Keith A. Havenstrite Puyallup, WA Susan M. Hecker Tacoma, WA Bryan S. Helsel San Antonio, TX Lucas W. Henn Youngstown, OH Mark W. Hennon Buffalo, NY Darren M. Hodgins Los Angeles, CA Edward Hong St. Petersburg, FL George W. Hubbard Norfolk, VA Brannon R. Hyde Austin, TX Moheb S. Ibrahim Kanata, Canada Samuel P. Jacks Jacksonville, FL Harsh Jain Hershey, PA William A. Jakobleff Jr. Yonkers, NY David J. Kaczorowski York, PA Tara B. Karamlou San Francisco, CA Nicholas J. Karis Rochester, NY Riny A. Karras Silver Spring, MD Edmund S. Kassis Columbus, OH W. B. Keeling Atlanta, GA Seyed M. Khalafi Forth Worth, TX Tanveer A. Khan Danville, CA Abbas Khani-Hanjani Edmonton, Canada Fawad N. Khawaja Jacksonville, FL Jonathan Kiev Huntington, WV Jae Y. Kim Duarte, CA Samuel S. Kim Tucson, AZ Paul S. Koh Eugene, OR Mwazhuwa L. Ray Kuretu Lewes, DE Sean J. Kwon Great Neck, NY Shelly C. Lall Traverse City, MI Yoan Lamarche Quebec, Canada Martin LeBoutillier York, PA Petros G. Leinonen San Antonio, TX Jeremy E. London Savannah, GA Joseph G. Lugo Chesterfield, MO Ryan A. Macke Madison, WI Jose M. Maquilan Moorestown, NJ Robert G. Matheny Alpharetta, GA Thomas S. Maxey Charlotte, NC Deborah B. McCollum Amarillo, TX Stephen H. McKellar Salt Lake City, UT Jeffrey S. Miller Atlanta, GA Daniela Molena Baltimore, MD Michael C. Monge Chicago, IL Emmanuel Moss Atlanta, GA Daniel E. Mumme Tacoma, WA Ashok Muralidaran Portland, OR Sundeep Patel Paradise Valley, AZ Harrison T. Pitcher Philadelphia, PA Joel E. Price Baltimore, MD Mohammed A. Quader Richmond, VA Danny Ramzy Los Angeles, CA Dan J. Raz Duarte, CA George R. Reiss III Park City, UT Laki J. Rousou Concord, NH Ahmad Y. Sheikh Stanford, CA Michael S. Shillingford Jacksonville, FL Ramesh Singh Louisville, KY Frank N. Slachman Sacramento, CA Ronald D. Smith Bradenton, FL William E. Stansfield Chapel Hill, NC Chad N. Stasik San Antonio, TX William Tisol Milwaukee, WI Michael Zhen-Yu Tong Cleveland, OH Wilson S. Tsai Concord, CA Dennis Vega Tenafly, NJ Christopher K. Vincent Winchester, VA Rochus K. Voeller St. Paul, MN Lewis Wetstein Freehold, NJ Brian B. Whang Boston, MA Bryan A. Whitson Columbus, OH Daniel C. Wiener Boston, MA Andrea S. Wolf New York, NY Berhane Worku Brooklyn, NY Roh Yanagida Lexington, KY James J. Yun Lebanon, NH Robert F. Zink St. Joseph, MO International Members Ihab M. Abdelfattah Cairo, Egypt Rajat Agarwal Delhi, India Aldo Manuel Alvarez Moran Ixtapaluca, Mexico José M. Arribas Wan Ki Baek Reza Bagheri Sohail Khan Bangash Aureliu A. Batrinac Hector Bedoya Copello Denis Berdajs Eduardo Bernabeu Alessandro Bertani Giuseppe Bruschi Lucio Careddu Jui-Chih Chang Murcia, Spain Incheon, South Korea Mashhad, Iran Karachi, Pakistan Chisinau, Moldova Lima, Peru Lausanne, Switzerland Alicante, Spain Palermo, Italy Milan, Italy Bologna, Italy Hualien, Taiwan Arnaud F.P. Charpentier Luxembourg, Luxembourg Vijit K. Cherian Soon-Ho D. Chon Sabine H. Daebritz Danato D Agostino Fabio Davoli Dina De Bock Eva Maria B. Delmo Walter Rajesh N. Desai Shirish M. Dhoble Pascal M. Dohmen Joel Dunning Rodolphe Durieux Chizoba A. Efobi Ahmed M. El-Eshmawi Achmad Faisal Theodor J. M. Fischlein Antonino Ginel Chennai, India Jeju, South Korea Duisurg, Germany Bari, Italy Parma, Italy Edegem, Belgium Berlin, Germany Ahmedabad, India Indore, India Berlin, Germany Kirkby Stephen, United Kingdom Liege, Belgium Benin City, Nigeria New York, NY Jakarta, Indonesia Nuremberg, Germany Barcelona, Spain Fabian Andres Giraldo Vallejo Bucaramanga, Colombia Hardy Gonzales Sanchez Sr. Julia M. Gotte Yopie A. Habibie Ashutosh Hardikar Jonathan M. Hemli Yuqing C. Huang Marco A. Iñiguez-Garcia Fernando O. Jemio Fuad Jindan Vikram Jitendra Masashi Kai Jayaprasanna G. Kallukudige Isamu Kawase Kyung Hwa Kim Soo-Sung Kim Dohun Kim Junjiro Kobayashi Maciej K. Kolowca Martin Kostelka Luiz F. Kubrusly Suha Kucukaksu Aslihan Kucuker Hirotsugu Kurobe Kenji Kuwaki Lima, Peru Stuttgart, Germany Banda Aceh, Indonesia Sandy Bay, Australia New York, NY Beijing, China Mexico City, Mexico Santana Cruz, Bolivia Doha, Qatar Aberdeen, United Kingdom Valhalla, NY Nagpur, India Tokyo, Japan Jeonju, South Korea Gyeongju, South Korea Seoul, South Korea Osaka, Japan Rzeszow, Poland Leipzig, Germany Curitiba, Brazil Istanbul, Turkey Ankara, Turkey Tokushima, Japan Tokyo, Japan Stephen M. Langley Hecheng Li Ricardo Lopez Nicola Luciani Claudio Luciani Pavlo Lukach Daniele Maselli Katsuhiko Matsuyama Henry Medina Praveen Menon Abdelrahman M. Mohammed Julio Moron Castro Tomasz Mroczek Christian Munoz-Guijosa Masato Mutsuga Gencho Nachev Aleksandar Nikolic Kazuma Okamoto Alexandre de Oliveira Hideki Oshima Takeyoshi Ota Eduard Permanyer Portland, OR Shanghai, China Bogota, Colombia Rome, Italy Roma, Italy Mukachevo, Ukraine Roma, Italy Tokyo, Japan Cali, Colombia Ernakulam, India Cairo, Egypt Lima, Peru Krawkow, Poland Barcelona, Spain Nagoya, Japan Sofia, Bulgaria Podgorica, Montenegro Tokyo, Japan Sao Paulo, Brazil Nagoya, Japan Chicago, IL L Ametlla del Vallès, Spain Javier A. Pinedo Onofre Sr. San Luis Potosí, Mexico Jose L. Pomar Sotirios Prapas Sarju Ralhan Sr. Sundar Ramanathan Marc S. Rebel Olaf Reinhartz Kisaburo Sakamoto Takahisa Sakurai Marcos N. Samano Alok K. Sharma Satyanand B. Shastri Yaxing Shen Abdalla Shousha Francesco Siclari Jorge Sierra Alan D. Sihoe Jorge Alberto Silva Vivas Janusz H. Skalski Kiron K. Somasekharan Nair Olaf Stanger George Stavridis Ivan C. Stojanovic Xiaoning Sun Prajeesh Thiru Chaithanya Yoshiyuki Tokuda Zoran Trifunovic Masaki Tsukashita Takuro Tsukube Yoshio Tsunezuka Murali P. Vettath Kentaro Yamane Yoo Sang Yoon Haiyu Zhou Barcelona, Spain Athens, Greece Ludhiana, India Coimbatore, India Auckland, New Zealand Stanford, CA Shizuoka, Japan Nagoya, Japan Sao Paulo, Brazil Jaipur, India Mumbai, India Shanghai, China Cairo, Egypt Logano, Switzerland Geneva, Switzerland Hong Kong Mexico City, Mexico Krawkow, Poland Wilkes Barre, PA Berne, Switzerland Voula, Greece Belgrade, Serbia Shanghai, China Kozhikode, India Nagoya, Japan Belgrade, Serbia New York, NY Kobe, Japan Kanazawa, Japan Kozhikode, India Hershey, PA Busan, South Korea Boston, MA
7 STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 TUESDAY/WEDNESDAY ISSUE 7 Members Who Joined After 2013 STS Annual Meeting Associate Members Adriana Arcila San Juan, PR Solomon Aronson Chapel Hill, NC Jacqueline D. Arroyo Brighton, MA Iman F. Aziz Atlanta, GA Sharon L. Bailey Windsor, CO Glenn C.Bailey Jr. Washington, DC Evelyn Baram-Clothier Philadelphia, PA Janie S. Baranyay Lakehurst, NJ Bradley P. Barrett Lynwood, WA Kenneth G. Barron Los Angeles, CA David E. Bateman Kirby, WV Catherine V. Beckmann Albuquerque, NM Kimberly L. Behrens Baltimore, MD Daniel A. Bentley Rockford, IL Romilla Y. Bijlani Portland, OR Thomas A. Bowdle Seattle, WA Elizabeth R. Burckardt Louisville, KY Jennifer L. Burnette Alexander, AR Kathleen Carberry Houston, TX Daniel R. Cozadd Dublin, OH Roselyn David Los Angeles, CA Maureen R. Del Re Port Washington, NY Marie L. Delaney Karns City, PA Michael Djuric Darien, IL Joseph P. Drozda Jr. Chesterfield, MO James S. Eadie Austin, TX Clifford E. Fonner Lenexa, KS Ashley L. Foster Glen Allen, VA Emily C. Guderian Greenville, SC Punkaj Gupta Little Rock, AR Elizabeth Habermann Rochester, MN Marjorie A. Hamm Allentown, PA Jeanette M.P. Harris Cincinnati, OH Shaun M. Hart Leo, IN Kenneth A. Haverland Seattle, WA Joshua A. Hemmerich Chicago, IL Shannon E. Henderson Colorado Springs, CO Kathryn A. Howell Roswell, GA Julie A. Judge-Proulx Portsmouth, NH Samir R. Kapadia Cleveland, OH Sylvia L. Kirqis Langburg, MI Joseph D. Kuwahara Orange, CA Jason K. Lempel Cleveland, OH Joshua J. Lowman Gainesville, GA Gary M. Maras Erie, PA Kathleen M. Masket Portola Valley, CA Verghese Mathew Rochester, MN Lisa M. Mauricio Houston, TX Ginger McCabe Boise, ID Jacqueline F. Metzger Williamston, MI Nicole M. Michaud Franklin, TN Janet Morra Tampa, FL Vinay M. Nadkarni Philadelphia, PA Karen M. Odroniec New Brunswick, NJ Marcie L. O Reilly Loma Linda, CA Jessica S. Parkyn Yuba City, CA Cynthia A. Paulikas Orlando, FL Geneva M. Preston Danville, KY Satish K. Rajagopal Newton, MA Crystal L. Rene de Cotret Long Beach, CA Emmanuel D. Resendes Westport, MA Jilda A. Ross Boardman, OH Clinton H. Seales Nashville, TN Catherine M. Shim Wailuku, HI Nelofar Siddiqui Mission Viejo, CA Marina L. Silguero San Antonio, TX James E. Tcheng Durham, NC Naomi L. Teperow Sheila G. Trotter Linda J. Veit Annette L. Webb Ursula K. Weiss Tammie J. Wharton Ned T. Wiggs Leah A. Zupancich Erie, PA Brentwood, TN Syracuse, NY Poplar Bluff, MO Miami Beach, FL Loma Linda, CA Chattanooga, TN Crystal, MN Candidate Members Aaron M. Abarbanell Atlanta, GA Mohammed N. Abd Al Jawad Cairo, Egypt Muhammad Aftab Houston, TX Jeremiah G. Allen Philadelphia, PA Amal A. Alotaibi Riyadh, Saudi Arabia Mara B. Antonoff Olivette, MO Scott J. Banuelos Danville, VA Christopher M. Bariana Cleveland, OH Edo K.S. Bedzra Seattle, WA Justin D. Blasberg Boston, MA Michael Bolanos Lexington, KY Jamil F. Borgi Seattle, WA Christopher R. Burke Seattle, WA Neil F. Cambronero San Francisco, CA Philip W. Carrott Jr. Ann Arbor, MI Richard N. Carter Pearland, TX Alfred J. Casillan Chicago, IL Edward Y. Chan Seattle, WA Krish Chaudhuri Hobart, Australia Kezhong Chen Beijing, China Joshua S. Chung Los Angeles, CA George M. Comas Atlanta, GA Jeremy Conklin Albany, NY Marzia Cottini Oggebbio, Italy Jordy Cox San Francisco, CA John M. Craig Memphis, TN Janet P. Edwards Calgary, Canada Amanda L. Eilers San Antonio, TX James R. Fenton Salt Lake City, UT Jessica Forcillo Montreal, Canada Neil I. Galindez Marc Gibber Erin A. Gillaspie Lawrence E. Greiten Katherine B. Harrington Matthew J. Henry Casey P. Hertzenberg Eric B. Howell Kelley A. Hutcheson Scott D. Johnson Bakri Kaakeh Fabian A. Kari John C. Keech Puja G. Khaitan Karen M. Kim Aaron M. Kime Adam H. Lackey Sharon B. Larson Karl K. Limmer Martha A. Malone Carlo O. Martinez Giulio Maurizi Chris K. Mehta Serguei Melnitchouk Timothy M. Millington Nathan M. Mollberg Katie O Sullivan Harold C. Ott Vassil G. Papantchev Ana M. Parsee Jay B. Patel Yury Peysakhovich Timothy J. Pirolli Matthew E. Powers Matthew J. Reinersman Michael P. Robich Manu S. Sancheti Friederike Schlingloff Elliot L. Servais Bilal M. Shafi The Original Cosgrove Mitral Valve Retractor & McCarthy Mini-Sternotomy Retractor EXCLUSIVE DESIGN & MANUFACTURING BY KAPP SURGICAL Dallas, TX Baltimore, MD Rochester, MN Rochester, MN Plano, TX Houston, TX Overland Park, KS Seattle, WA St. Louis, MO Johns Island, SC Portland, OR Freiburg, Germany Coralville, IA Houston, TX Philadelphia, PA Pasadena, CA Royal Oak, MI Miami, FL Charlestown, MA Owasso, OK San Antonio, TX Rome, Italy Chicago, IL Boston, MA Malden, MA Seattle, WA Drumree, Ireland Boston, MA Sofia, Bulgaria Baltimore, MD Atlanta, GA Hamilton, Canada Palo Alto, CA New York, NY Rochester, MN Cleveland, OH Atlanta, GA Hamburg, Germany Brookline, MA Philadelphia, PA Ibrahim Sultan Erik A. Sylvin Paul C.Y. Tang Matthew D. Taylor Tom P. Theruvath Hadi D. Toeg Dimitrios Topalidis Shinya Unai Marian Urban Panayotis Vardas Dustin M. Walters Brody P. Wehman Benjamin Wei Ahmad Zeeshan Yong Zhan Philadelphia, PA Philadelphia, PA Durham, NC Charlottesville, VA Charleston, SC Ottawa, Canada St. Paul, MN Philadelphia, PA Prague, Czech Republic Indianapolis, IN Charlottesville, VA Baltimore, MD Birmingham, AL New Haven, CT Brookline, MA Pre-Candidate Members David C. Adams Midvale, UT Jada M. Aikman Suffolk, VA Andrea L. Axtell San Franciso, CA Meredith A. Baker Philadelphia, PA Tomas J. Birriel Breinigsville, PA Matthew C. Black Louisville, KY Jordan P. Bloom Charleston, MA Jacqueline Y. Boehme Winter Springs, FL Sarah J. Counts Branford, CT Garrett N. Coyan Kansas City, KS Benjamin C. Degner Chicago, IL Brett F. Duncan Chicago, IL Brian R. Englum Durham, NC John M. Fallon II Lebanon, NH Douglas M. Farmer Kaneohe, HI Benoit Frechet Montreal, Canada Juan Gallegos Knoxville, TN Asvin M. Ganapathi Durham, NC Jason P. Glotzbach Durham, NC Kevin A. Graham Indianapolis, IN Christina L. Greene South Pasadena, CA Joshua C. Grimm Baltimore, MD Continued on following page
8 8 TUESDAY/WEDNESDAY ISSUE STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 Continued from previous page Nabeel Habib Gul Falcon Heights, MN Donald G. Harris Baltimore, MD Sigurd Hartnett Vermillion, SD Cristina M. Joy-Perez Pittsburgh, PA Humberto Juarez City of Panama, Panama Kellianne C. Kleeman Ann Arbor, MI Johannes R. Kratz Boston, MA Amie J. Kraus Valley Stream, NY Michael H. Kwon Boston, MA Nguyen M. Le New York, NY Gal Levy Hoboken, NJ Clauden Louis Silver Spring, MD Amin Madani Montreal, Canada Jesse L. Madden Salt Lake City, UT Alexandro T. Marginean Round Lake, IL Farooq M. Mirza Iowa City, IA Tyler O. Murray Houston, TX Dylan R. Nieman Pittsford, NY Cyrus R. Orandi St. Louis, MO Colleen M. Pietras Hershey, PA Sheelagh M. Pousatis Washington, DC Brian B. Rezvani Washington, DC Joshua E. Rosen New Haven, CT Pamela P. Samson Webster Groves, MO Laura A. Scrimgeour Denver, CO Asha J. Shah Royal Oak, MI Charles P. Smoot El Paso, TX Paul J. Speicher Durham, NC Corinne W. Tan Indianapolis, IN Michael T. Torchia St. Paul, MN Charles R. Vasquez Santa Monica, CA Walter C. Wakwe Atlanta, GA Jared A. White Brandon, MS Stephanie G. Worrell Los Angeles, CA Brittany A. Zwischenberger Lexington, KY Program update Early Riser Session #7 Reinventing Your Career: Pathways Outside the Operating Room This course will now be held in Grand Ballroom 1-3. Basic Science Research: General Thoracic David R. Jones, of New York, will co-moderate this session. Shuttle Bus Schedule Complimentary shuttle service is provided between the Orlando World Center Marriott and the Gaylord Palms Resort. Tuesday, January 28 6:15 a.m. 6:00 p.m. Wednesday, January 29 6:15 a.m. 11:30 a.m. *Times subject to change. Please see the schedule in each hotel s lobby for the most up-to-date information. Aortic Arch Advancements for Infants T he optimal treatment for infants with aortic coarctation and hypoplastic aortic arch is controversial. Possible techniques include patch aortoplasty, insertion of an interposition graft, subclavian flap aortoplasty, and, when feasible, coarctectomy with extended end-toend anastomosis, but they all have their disadvantages, said Carlos M. Mery, MD, MPH and his colleagues. During his Tuesday morning presentation, Complete Autologous Aortic Arch Reconstruction (Aortic Arch Advancement) for Hypoplastic Aortic Arch in Infants: A Superior Surgical Technique, Dr. Mery will discuss a study that he conducted with fellow researchers at Texas Children s Hospital and Baylor College of Medicine, Houston. The goal of the study was to investigate the long-term outcomes of infants with hypoplastic aortic arch who were treated using a single-stage, all-autologous aortic CARLOS M. MERY, MD, MPH arch reconstruction technique aortic arch advancement (AAA). Dr. Mery will discuss the surgical outcomes of 245 infants who underwent AAA at Texas Children s Hospital from 1995 to AAA was performed by median sternotomy with cardiopulmonary bypass (CPB), deep hypothermic circulatory arrest (DHCA), and/or antegrade cerebral perfusion (ACP). AAA consisted of coarctectomy, division of the aortic isthmus, and end-to-side anastomosis of the descending aorta to the distal ascending aorta/proximal arch. A total of 45% of the infants were females. The patients had a median age of 13 days and an average weight of 3.3 kg. Genetic abnormalities were identified in 17% of the patients. The authors observed a very low morbidity profile, including neurological complications (stroke or seizures) in 1% of the patients and left bronchial compression in one patient (0.4%). Postoperative bronchoscopy, performed routinely since 2007, identified vocal cord paresis in 41% of the 81 screened patients; however, none had clinical residual paresis at their last follow-up. Recoarctation requiring reintervention was rare. In a median follow-up of 66 months, only seven patients (3%) had a reintervention (four catheter based and three surgical), which occurred at a median of 5 months after repair. Using AAA conferred a 2% perioperative mortality rate and excellent 10-year survival rates, according to the researchers. Our study shows that AAA is safe, effective, and durable. It has a low complication rate, a low rate of long-term reintervention, and its advantages include native tissue-totissue reconstruction, while preserving the potential for further growth, Dr. Mery said. Congenital Session: Pediatric Congenital III TUESDAY, 11:00 a.m. 12:30 p.m. Grand Ballroom 4 6 Mortality at 30 Days Underrepresents Risk Thirty-day mortality is a commonly reported outcome measure in national databases such as the STS National Database and the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). These measures are often cited when presenting risks to patients in informed consent discussions. Given the serious nature of surgical resection for thoracic malignancies and the fact that patients undergoing these operations are often older and carry comorbidities, Robert R. McMillan, MD and his colleagues at Memorial Sloan-Kettering Cancer Center, New York, hypothesized that 30-day mortality underrepresents the true perioperative risk. As the Medicare global period encompasses 90 days postoperatively, the researchers were able to compare mortality rates at 90 vs. 30 days across several operations for different thoracic malignancies. ROBERT R. MCMILLAN, MD During his Tuesday morning presentation, The Outcome Measure 30-Day Mortality Underestimates Risk of Early Mortality After Major Resections for Thoracic Malignancies, Dr. McMillan will discuss the results of data obtained on 7,646 surgical resections that were performed for lung cancer (6,119), esophageal cancer (1,258), or mesothelioma (269) from 1999 to Among the different cancers and across various operations, on average, the additional mortality incurred in the time period from day 31 to day 90 (1.4%, CI ; n = 111) was similar to the mortality occurring by day 30 (1.2%, CI ; n = 95). The overall 90-day mortality (2.7%, CI , n = 206), therefore, was more than double that of the 30-day mortality. The major finding in this study is that considerable early mortality attributable to surgery occurs beyond the first 30 days after surgery as well as after initial discharge from the hospital among patients undergoing surgery for thoracic malignancies. By examining the postoperative day and postdischarge periods, we ascertained that the majority of these additional deaths were attributable to complications related to surgery, he said. With 40% of deaths within 90 days occurring outside either the 30- day or discharge definitions of operative mortality, these measures underreport the actual risk of early death after these procedures. As cancer surgery constitutes a significant portion of the practice of general thoracic surgery, we would recommend that national databases such as the STS General Thoracic Surgery Database and the ACS- NSQIP consider the inclusion of 90- day mortality in their data collection, Dr. McMillan said. General Thoracic Session: Lung Cancer II TUESDAY, 8:15 a.m. 10:15 a.m. Grand Ballroom 8A
9 THE POWER OF MAQUET: COMPREHENSIVE PRODUCTS AND THERAPEUTIC SOLUTIONS MAQUET The Gold Standard. VASOVIEW HEMOPRO Endoscopic Vessel Harvesting CARDIOSAVE / SENSATION PLUS IAB Therapy CARDIOHELP System MIRA-i CS System for Minimally Invasive Cardiac Surgery ACROBAT System for Off-Pump Cardiac Surgery (OPCAB) VARIOP Modular Wall system YUNO OTN and MAGNUS Surgical Tables MODUTEC Ceiling Supply Units TEGRIS OR Integration System FLOW-i Anesthesia Delivery System HEMASHIELD, HEMAGARD, and CARDIOROOT vascular grafts ClearWay RX Local Drug Infusion Balloon Catheter and Xpress-Way RX Extraction Catheter Atrium OASIS Chest Drain and EXPRESS MINI Chest Drain POWERLED Surgical Lighting AT STS 2014, VISIT MAQUET BOOTH #813
10 10 TUESDAY/WEDNESDAY ISSUE STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 Evaluating High-Risk Criteria for Mitral Valve Therapies D efinitions of high-risk criteria can vary between clinical trials and the results of contemporary practice. Because of such possible disparities, it is important to assess how high-risk criteria used in trials fare outside the study setting. The current Real World Expanded Multicenter Study of the MitraClip System (REALISM) uses several inclusion criteria to help identify patients who may be at high risk for conventional mitral valve surgery, according to Damien J. LaPar, MD, of the University of Virginia, Charlottesville, and his associates. They performed a study to evaluate contemporary surgical outcomes for high-risk patients who meet these REALISM-defined criteria. Their goal was to provide a possible benchmark from which to evaluate the appropriateness of how treatments conventional surgery and MitraClip are allocated for high-risk mitral disease. Dr. LaPar will report their results in a Tuesday morning presentation, Multicenter Evaluation of High- Risk Mitral Valve Operations: Implications for Selection of Conventional Surgery vs. Novel Transcatheter Valve Therapies. The investigators used the STS National Database to assess patients undergoing isolated mitral valve surgery over a 12-year period at 17 different hospitals. Patients were stratified into high-risk vs. non high-risk cohorts based upon clinical DAMIEN J. LaPAR, MD criteria similar to those used in the REALISM trial. The researchers used mixed effects multivariable regression modeling to evaluate study endpoints as outcomes across hospitals. Of 2,440 isolated mitral operations, 698 (29%) were high risk as defined by REALISM criteria. These criteria include a predicted procedural risk of mortality (PROM) calculated using the STS surgical risk calculator of at least 12%; functional mitral regurgitation with an ejection fraction less than 40; age greater than 75 years with an ejection Explore STS History with Special Annals Supplement To honor the Society s 50th anniversary, the January issue of The Annals of Thoracic Surgery features a very special supplement highlighting important moments in STS history. Pick up a copy of the supplement at the STS Pavilion in the Central Atrium or at The Annals of Thoracic Surgery Booth #1400 in the Exhibit Hall. Visit to access it online. fraction less than 40; reoperation with patent grafts; and at least three STS high-risk factors. Median STS PROM for high-risk patients was 6.6% vs. 1.6% for non high-risk patients, a significant difference (P <.001). High-risk patients from the Database more commonly underwent mitral valve replacement, as well as urgent (30% vs. 19%, P <.001) and emergent (3.2% vs. 1%, P <.001) operations, compared with non high-risk patients. As expected, high-risk patients also incurred significantly higher morbidity and operative mortality (7% vs. 1.6%), longer ICU stays (48 vs. 41 hours), and longer hospital stays (7 vs. 6 days); in all cases P the improvement of this Society, the specialty of cardiothoracic surgery, and the care of patients with cardiothoracic disease. There is no surgeon, past or present, more deserving of this award. Dr. Mathisen heads the Division of Thoracic Surgery at Massachusetts General Hospital in Boston, where he is also the Program Director for Cardiothoracic Surgery. In addition, he is the Hermes C. Grillo Professor of Surgery at Harvard Medical School. He has held leadership positions with virtually every major organization in cardiothoracic surgery. Dr. Mathisen was the STS President and continues to serve the Society as a member of the Finance and Nominating Committees. He also is a Deputy Editor for The Annals of Thoracic Surgery. Dr. Mathisen chairs the Joint Council on Thoracic Surgery Education. He previously served as a Director for both The American Board of Thoracic Surgery and the Thoracic Surgery Foundation for Research and Education, as a Councilor for the American Association for Thoracic Surgery, and as President of the Thoracic Surgery Directors values were <.001. However, among the REALISM criteria used to select high-risk patients, the only criteria that were significantly associated with operative mortality were an STS PROM greater than or equal to 12% (P <.001) and three or more highrisk STS criteria (P =.01). These data suggest that certain REALISM criteria may not represent patients at high risk of death with surgery, according to the researchers. With this in mind, in addition to conventional STS criteria, risk assessment by surgeons is essential to direct the appropriate treatment allocation for high-risk mitral disease, the researchers concluded. Adult Cardiac Session: Mitral Valve TUESDAY, 8:15 a.m. 10:15 a.m. Grand Ballroom 7A Distinguished Service Award Continued from page 1 DOUGLAS J. MATHISEN, MD Association. He is the recipient of many honors, including being named a 2013 Honorary Member of the European Society of Thoracic Surgeons and one of Boston s Top Doctors by Boston Magazine in 2012 and All members should take inspiration from someone like Doug and the recognition he receives, not only from STS, but also from across our field, for the breadth of his contributions, said Dr. Wood. While we may not each achieve the level of service or make as large an impact on the specialty as he has, each of us should be inspired by him to see what is possible. It should encourage us to take on any task that improves our specialty or our community rather than ourselves, and to do it with enthusiasm, and do it well. Dr. Mathisen received his undergraduate degree from the University of Illinois in Champaign. He completed his medical degree at the University of Illinois at Chicago, where he was a member of the national medical honor society Alpha Omega Alpha. He has been an STS member since 1987.
11 STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 TUESDAY/WEDNESDAY ISSUE 11 Refining Risk Adjustment for Congenital Heart Surgery T he most common forms of risk adjustment for pediatric and congenital heart surgery are based mainly on the estimated mortality risk of the primary procedure, independent of many preoperative patient factors. On Tuesday morning, Jeffrey P. Jacobs, MD, of the Johns Hopkins All Children s Heart Institute, St. Petersburg, Fla., will present results of a study that assessed the importance of patientspecific preoperative factors in pediatric and congenital cardiac surgical risk models. All index cardiac operations in the STS Congenital Heart Surgery Database (CHSD) from 2010 to 2012 were eligible for the study. Researchers analyzed 25,476 operations, which had an overall discharge mortality of 3.7% (n = 943). Patients weighing less than 2.5 kg undergoing patent ductus arteriosus At the Business Meeting last night, STS membership selected G. Alexander Patterson, MD as the new Editor- Elect of The Annals of Thoracic Surgery. Over the next year, Dr. Patterson will work closely with current Editor L. Henry Edmunds Jr., MD, whose term ends at the STS 51st Annual Meeting in January I m absolutely thrilled and honored about this opportunity, Dr. Patterson said. I look forward to working with the STS leadership to take The Annals to the next level. Dr. Patterson has been Chief of the Division of Cardiothoracic Surgery and Evarts A. Graham Professor of Surgery at Washington University in St. Louis since He has been with Washington University since Prior to that, he held a JEFFREY P. JACOBS, MD closure were excluded. Centers with greater than 10% missing data and patients with missing data for discharge mortality or other key variables, including preoperative factors, were excluded from the study, according to the researchers. Preoperative factors were included in the analysis if patient agegroup specific prevalence was greater than 2% or if the number of associated deaths was greater than 19. Death rates of patients with and without each factor were compared using Fisher s exact test. In his presentation, Refining Risk Adjustment for Pediatric and Congenital Heart Surgery The Importance of Patient-Specific Preoperative Factors: An Analysis of the STS Congenital Heart Surgery Database, Dr. Jacobs will discuss the preoperative factors examined and how these differed in significance number of positions at the University of Toronto. Dr. Patterson has served as President of the American Association of Thoracic Surgery and is completing his term as President of the Thoracic Surgery Foundation for Research and Education. We have been fortunate to have had some of the greatest giants in cardiothoracic surgery as editors of The Annals of Thoracic Surgery, including current Editor Hank Edmunds. We are fortunate to have another giant, Alec Patterson, fill this extremely important role. I am confident that under his leadership, The Annals will continue to be the preeminent journal for our specialty, said STS President Douglas E. Wood, MD, who led the Editor-Elect Search Committee. Dr. Patterson s editorial experience includes 16 years with The Journal of Thoracic and Cardiovascular Surgery, 12 of which were served as Section Editor for General Thoracic Surgery. He also served as the First Thoracic Deputy Editor of the American Journal of Transplantation, Associate Editor of The Journal of Heart and Lung among the assessed populations. Ultimately, for neonates, infants, and children, discharge mortality was found to be significantly associated with the preoperative factors of mechanical circulatory support, renal dysfunction, shock, and mechanical ventilation (all with P values <.0001). Other factors were significant in more individualized populations. For example, the only preoperative factors significant in adults with congenital heart disease were preoperative mechanical ventilation and preoperative neurological deficit, while others, such as preoperative gastrostomy, were significant for infants and children but not neonates. Current CHSD risk adjustment is based on estimated risk of mortality of the primary procedure of the operation, as well as age, weight, and prematurity. The inclusion of additional patient-specific preoperative factors in risk models for pediatric and congenital cardiac surgery could lead to increased Editor-Elect for The Annals of Thoracic Surgery Chosen G. ALEXANDER PATTERSON, MD Transplantation, and a member of the Transplantation Proceedings Editorial Board. He has more than 400 published research papers and was the Senior Editor for the textbook Pearson s Thoracic and Esophageal Surgery, third edition. I have devoted my entire STS Past Presidents precision in predicting risk of operative mortality and comparison of observed to expected outcomes, according to the researchers. One important result of this analysis is that beginning with the Spring 2014 STS-CHSD Feedback Report, a new STS-CHSD Risk Model will be used that will include a number of new patient-specific preoperative factors, including chromosomal abnormalities, syndromes, noncardiac congenital anatomic abnormalities, and preoperative factors, Dr. Jacobs said. This new STS-CHSD Risk Model will improve the ability of the STS- CHSD to be used as a tool to improve the quality of surgical care delivered to patients with pediatric and congenital cardiac disease. Congenital Session: Pediatric Congenital II TUESDAY, 8:15 a.m. 10:15 a.m. Grand Ballroom 4-6 career to scholarship and academic productivity as a means to foster the development of thoracic surgery, Dr. Patterson said. To become Editor-Elect of one of the major journals in the field was an extension of what I ve worked for over my whole career. On Saturday evening, a number of STS Past Presidents mingled at a reception at the Isleworth Country Club.
12 12 TUESDAY/WEDNESDAY ISSUE STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 New Learning Tools Developed for CT Surgery Education C ardiothoracic surgical education faces multiple challenges. The pace of rapidly advancing knowledge, the need for new skills, and the increase in case complexity have skyrocketed in recent years. New barriers also have arisen, including the mandated reduction of duty hours and the overall diminishing priority of teaching at many institutions. The importance of these problems is significant and may be reflected in the current failure rates of cardiothoracic trainees on The American Board of Thoracic Surgery (ABTS) exam, according to Mara B. Antonoff, MD, of Washington University, St. Louis, and her colleagues. Dr. Antonoff will discuss a new training format to address these challenges in her Tuesday morning presentation, Novel Use of Online Learning to Supplement Thoracic Surgical Training: Promising Results of a Moodle-Based Multi- Institutional Pilot Study. MARA B. ANTONOFF, MD This research is incredibly timely, as the current state of thoracic surgical education is in flux. The issues related to adequate training of current trainees are immense and well known, and a number of interventions have been suggested. This study demonstrates the efficacy of a well-received approach through a pilot group of trainees and supports the rollout of the current thoracic surgery curriculum, which is based on a platform identical to the one used in this study, she said. New curricular models need to be developed to supplement on-theground teaching, and e-learning environments serve as a valid adjunct to clinical experiences. Dr. Antonoff and her colleagues hypothesized that Internet-based courses can be developed and implemented to allow learning of basic topics in cardiothoracic surgery. The researchers conducted a needs assessment based upon recent ABTS exam results. Four content experts developed four online self-study courses using a Moodle platform. Moodle is a free, open-source coursemanagement system that educators can use to create tailored online learning sites. Students from four US thoracic surgery training programs participated, accessing courses at their own pace. Each course included general and detailed readings, multimedia content, an open forum, and a question bank supported quiz (a score of at least 90% was required to pass, though multiple attempts were allowed to reach this goal). System use and exam data were tracked electronically, and T- tests were conducted to compare firstvs. final-year traditional-track trainees. In addition, post-course surveys were given to collect data on trainee attitudes. Thank you! A total of 19 students completed four courses on tracheal disease. The mean time students spent on each course was 1 hour and 21 minutes, and the mean number of quiz attempts needed to pass was Predictably, mean scores improved with successive attempts, and senior trainees showed a trend toward less time spent per course and fewer quiz attempts, according to the researchers. Post-course surveys demonstrated uniform agreement by the students that the content and quizzes were beneficial to their learning efforts and that the courses were easy to navigate. Cardiothoracic Surgical Education TUESDAY, 11:00 a.m. 12:30 p.m. Grand Ballroom 8B The Society of Thoracic Surgeons gratefully acknowledges the following sponsors for their support of the STS 50th Annual Meeting. This list is accurate as of December 10, STS Platinum Sponsor Provided $50,000 or more Abbott Vascular STS Gold Sponsors Provided $25,000 or more Ethicon, Inc. Medtronic St. Jude Medical, Inc. STS Silver Sponsors Provided $10,000 or more Biomet Microfixation HeartWare 51 st Annual Meeting & Exhibition San Diego, California January 24-28, The STS Meeting Bulletin The Official Newspaper of the STS 50th Annual Meeting STS STAFF Executive Director & General Counsel: Robert A. Wynbrandt Director of Marketing & Communications: Natalie Boden Communications Manager: Heather Watkins PUBLICATION STAFF Director, FMC Society Partners: Mark Branca Advertising Sales: Tracy Murray Publication Editors: Mark S. Lesney, Therese Borden Publication Designer: Yenling Liu Production Specialist: Maria Aquino Meeting Photography: Martin Allred Copyright 2014, The Society of Thoracic Surgeons 633 N. Saint Clair St., Suite 2320, Chicago, IL Produced and distributed by FMS Society Partners, a division of Frontline Medical Communications. All rights reserved. No part of this publication may be reproduced or transmitted in any form, by any means without prior written permission from STS. The opinions expressed in this publication are those of the presenters and authors, and do not necessarily reflect the views of the Society. Cover photo credit: Geoffrey Fritsch/thinkstockphotos.com
13 STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 TUESDAY/WEDNESDAY ISSUE 13 Colon Interposition Gives Positive Outcomes T he colon has proved useful for esophageal reconstruction, but the long-term frequency of regurgitation, aspiration, and graft redundancy is not well established, according to Christina L. Greene, MD, of the University of Southern California, Los Angeles. Dr. Greene and her colleagues performed a retrospective chart review to identify patients who received esophagectomy at least 10 years ago. This is the largest series on quality of life after esophagectomy with colon interposition and has the longest median follow-up of any study published on this topic, she said. Among the symptoms assessed were dysphagia, regurgitation, sweating with meals, and breathing difficulties. In her Tuesday presentation, Outcome With Colon Interposition 10 to 38 Years After Esophagectomy, Dr. Greene will discuss the follow-up of 63 patients who underwent colon interposition before April The indication for esophagectomy was cancer in 45 patients and benign disease in 18. The esophagectomy was vagal sparing in 48%, en-bloc in 38%, and transhiatal in 8% of patients. Median follow-up was 13 years (ranging from 10 to 38 years). Follow-up showed that the majority of patients (90%) had a normal weight or were overweight and were free of significant gastrointestinal symptoms. In addition, the median Gastrointestinal Quality of Life score was 3 out of 4, and results from the SF-36 survey were above the published means in all categories. Follow-up EGD in 30 patients at a median of 6 years showed no Barrett s in the residual esophagus. For these patients, nutritional status and alimentary satisfaction were excellent at 10 to 38 years after colon interposition. This suggests that the colon interposition should be the first choice conduit in patients expected to survive 10 or more years after esophagectomy, Dr. Greene said. General Thoracic Session: Esophageal TUESDAY, 8:15 a.m. 10:15 a.m. Grand Ballroom 7B Spirited Discussion Expected at STS I n Tuesday morning s STS session, a joint effort of The Society of Thoracic Surgeons and the Society for Vascular Surgery, cardiothoracic and vascular surgeons will provide perspectives on the contemporary management of type B aortic dissection as well as the management of severe carotid artery disease in patients undergoing coronary artery bypass grafting (CABG) surgery. These are very relevant topics that both specialties desire to manage, said session co-moderator A. Michael Borkon, MD, Director of Cardiovascular Surgery at The Mid America Heart Institute of Saint Luke s Hospital in Kansas City, Mo. The message is that treatment strategies will evolve through continued collaboration of our two societies. Session co-moderator Jeffery B. Dattilo, MD, of Vanderbilt University Medical Center in Nashville, Tenn., added: For years, there has been controversy regarding intervention on the high-grade carotid lesion while performing open coronary revascularization. I feel this is an ideal topic to discuss between the two specialties and perhaps come to a reasonable conclusion as to timing of these procedures utilizing data that is more compelling now than in years past. Attendees should understand modern treatment strategies of the high-grade carotid lesion and that these have evolved in the last couple of decades, Dr. Dattilo said. This could potentially impact practice patterns as to timing of carotid and coronary revascularization or whether combining these two procedures is recommended given the data. The session presents a great opportunity for discussion, and it should be spirited, said Dr. Borkon. STS TUESDAY, 11:00 a.m. 12:30 p.m. Grand Ballroom Extend Your Meeting Experience with STS Annual Meeting ONLINE Products Save 50% when you purchase STS 50th Annual Meeting Online and/ or STS/AATS Tech-Con 2014 Online before the end of the meeting! With these web-based video presentations, you can earn up to AMA PRA Category 1 Credits when you purchase both products. Watch sessions you are unable to attend or review sessions of special interest from your own home or office. Compatible with desktop and laptop computers, as well as ipad, iphone, and Android mobile devices, allowing you on-the-go access. Visit the online sales counter in the registration area to make your purchase today, or order online at Savings expire after January 29, Accreditation Statement The Society of Thoracic Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. STS 50th Annual Meeting Online The Society of Thoracic Surgeons designates this enduring material for a maximum of AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. STS/AATS Tech-Con 2014 Online The Society of Thoracic Surgeons designates this enduring material for a maximum of 13.5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
14 14 TUESDAY/WEDNESDAY ISSUE STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 Don t Miss STS University Course 1: TAVR/TEVAR, Guidewires, and Sheaths Juan A. Crestanello, MD, Columbus, Ohio, and Vinod H. Thourani, MD, Atlanta Course 2: ICU/Echo Haney Mallemat, MD, Catonsville, Md., and Glenn J. R. Whitman, MD, Baltimore Course 3: Advanced Endoscopy for Thoracic Surgeons Moishe Liberman, MD, PhD, Montreal, and Douglas J. Minnich, MD, Birmingham, Ala. Course 4: Short- and Long-term Circulatory/Respiratory Support Aaron M. Cheng, MD, Seattle, and Nicholas G. Smedira, MD, Cleveland Course 6: Mitral Valve Repair Vinay Badhwar, MD, Pittsburgh, and Aubrey C. Galloway, MD, New York Looking for a new opportunity? Visit the 2014 STS/CTSNet Career Fair Harbor Beach Ballroom Monday, January 27 11:00 a.m. 4:00 p.m. Tuesday, January 28 10:00 a.m. 3:00 p.m. WEDNESDAY, JANUARY 29 7:00 a.m. 9:00 a.m. 9:30 a.m. 11:30 a.m. Grand Ballroom Course 7: Enabling Technologies Facilitating Minimally Invasive Surgery (canceled) Course 8: Valve-Sparing Aortic Root Replacement Duke E. Cameron, MD, Baltimore, and Edward P. Chen, MD, Atlanta Course 9: Fontan Conversion and Maze Procedure Jeffrey P. Jacobs, MD, St. Petersburg, Fla. and Constantine Mavroudis, MD, Orlando Course 10: Novel Techniques in Esophageal and Tracheal Surgery Sidhu P. Gangadharan, MD, Boston, and Christopher R. Morse, MD, Boston Course 11: Robotic Simulation Robert J. Cerfolio, MD, Birmingham, Ala., and Richard S. Lazzaro, MD, New York Global Presence in Orlando L eaders of several international cardiothoracic surgical societies joined STS President Douglas E. Wood, MD for his presidential address. (From left to right) Francis D. Ferdinand, International Society for Minimally Invasive Cardiothoracic Surgery; Darcy Ribeiro Pinto Filho, Brazilian Society of Thoracic Surgery; Jose Luis Pomar, European Association for Cardio-Thoracic Surgery; Douglas E. Wood, The Society of Thoracic Surgeons; Lee Chuen Neng, Asian Society for Cardiovascular and Thoracic Surgery; and Dirk Van Raemdonck, European Society of Thoracic Surgeons. STS/EACTS Session Highlights Type A Dissection The best methods of repairing type A aortic dissection will be debated during Tuesday s session on STS/EACTS: Repair of Type A Aortic Dissection. The session is a collaborative effort between STS and the European Association for Cardio-Thoracic Surgery. Type A dissection used to be a lethal condition, said session co-moderator Joseph Bavaria, MD, of the Hospital of the University of Pennsylvania in Philadelphia. Advances in the 1980s and 1990s markedly improved morbidity and mortality, but there still are significant long-term problems with the remaining dissected aorta, he said, and there have been questions as to whether surgeons should modify the classic operation to address problems with the downstream aorta. Our speakers will be answering the fundamental questions on what is the next step to improve outcomes in aortic dissection, he said. A big debate has been whether to perform limited or more extensive operations, added session comoderator Martin Czerny, MD, MBA, of University Hospital Zurich. There has been a huge discussion to find the balance between restricting surgery to the immediate need for surviving the acute phase and treating the problem more extensively to JOSEPH BAVARIA, MD MARTIN CZERNY, MD, MBA prevent later need for reoperation in primary non-treated aortic segments, Dr. Czerny said. Our session will discuss physician variances in different parts of the world and the pros and cons to their approaches. Participants will learn the rationale for robust classic proximal aortic reconstruction in acute type A dissection, evaluate when to proceed with more extensive treatment options in acute type A dissection and identify when to choose an aortic root replacement (Bentall) during the treatment of acute type A dissection. I hope attendees both learn and appreciate the classic operation and how to apply it with expertise, but also understand that there are intriguing and compelling proposals for extended operations that have merit, and could potentially reduce long-term morbidity, mortality, and the need for reoperations, Dr. Bavaria said. We re not saying either way is right or wrong. We re just showing the two viewpoints so surgeons can make clear decisions. STS/EACTS: Repair of Type A Aortic Dissection TUESDAY, 8:15 a.m. 10:15 a.m. Grand Ballroom 8B
15 STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 TUESDAY/WEDNESDAY ISSUE 15 STS Exhibit Hall and Exhibitors A&E Medical Corporation 1127 Durham, NC A&E Medical s products include MYO/Wire temporary pacing wires, MYO/Wire II sternum wires, MYO/Punch rotating surgical punch, MYO/Lead disposable patient cable, and DoubleWire highstrength sternal closure system. Abbott Vascular 1221 Santa Clara, CA Abbott Vascular is uniquely focused on transforming the treatment of vascular disease and improving patient care by developing the latest medical device innovations, investing in research and development, and advancing medicine through training and education. For more information, visit Abiomed Inc. 320 Danvers, MA Accuray 1405 Sunnyvale, CA ACUTE Innovations 733 Hillsboro, OR Furthering its reputation as a leader in the thoracic industry, ACUTE Innovations continues to make advancements in chest wall stabilization technology. Stop by booth 733 to learn about ACUTE s cutting-edge products: RibLoc Rib Fracture Plating system, Biobridge Resorbable Chest Wall Stabilization Plate, and AcuTie Sternal Closure System. Aesculap Inc Center Valley, PA Aesculap Inc., a member of the B. Braun family of health care companies, is the world s largest manufacturer of surgical instrumentation. For more than 138 years, Aesculap has provided customers with surgical instrumentation for ENT, plastic and reconstructive, thoracic, microvascular, cardiovascular, and laparoscopic surgery. Alere Home Monitoring 1409 Orlando, FL The Alere VADCare Program provides equipment and monitoring services designed specifically for VAD patients in the home setting. The proprietary Alere VADWatch Telemonitoring Program allows VAD coordinators to monitor patients after discharge and receive alerts when critical patient values are outside of pre-established acceptable ranges. Ambu Inc Glen Burnie, MD American Association for Thoracic Surgery (AATS) L100-L102 (foyer) Beverly, MA Founded in 1917, the American Association for Thoracic Surgery is dedicated to excellence in research, education, and innovation in cardiothoracic surgery and has become an international professional organization of more than 1,300 of the world s foremost cardiothoracic surgeons. Continued on following page NOTE: Exhibitors highlighted in blue are advertisers of The STS Meeting Bulletin. The information for these products and services was provided by the exhibitors, and inclusion in this publication should not be construed as a product endorsement by STS. As of January 25, 2014 Lunch Seating STS MUSEUM Entrance L100 L104 L106 L108 L110 L112 L116 L118 L120 L122 STS Exhibit Hall Hours Sunday, January 26 4:30 p.m. 6:30 p.m. Monday, January 27 9:00 a.m. 4:30 p.m. Tuesday, January 28 9:00 a.m. 4:30 p.m.
16 16 TUESDAY/WEDNESDAY ISSUE STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 Continued from previous page Annals of Thoracic Surgery, The 1400 Philadelphia, PA Elsevier proudly publishes The Annals of Thoracic Surgery, the official publication of The Society of Thoracic Surgeons. Trust Elsevier to deliver superior reference information and decision support tools. With an extensive media spectrum print, online, and handheld Elsevier is able to supply the information you need in the most convenient format. ATMOS 935 Allentown, PA ATMOS offers the finest quality, patientfriendly devices that empower medical professionals to provide the best possible quality of care. The ATMOS philosophy, combined with ambitious and team-oriented employees, continues to facilitate the company s continued success. For a better life. AtriCure Inc. 615 West Chester, OH AtriCure, your partner in Afib solutions, features the only FDA-approved surgical AF device, Synergy RF, and Cryothermic Ablation energy devices. It also provides the only Maze IV AF certification course. AtriCure s portfolio includes the AtriClip, which is the only complete LA Appendage management solution that permanently isolates both mechanically and electrically. Baxter Healthcare 1021 Deerfield, IL As a global, diversified health care company, Baxter International Inc. applies a unique combination of expertise in medical devices, pharmaceuticals, and biotechnology to create products that advance patient care worldwide. B. Braun Interventional Systems 1038 Bethlehem, PA Berlin Heart Inc The Woodlands, TX Berlin Heart, the only company worldwide that develops, manufactures, and distributes VADs for patients of every age and body size. EXCOR Pediatric provides medium- to long-term circulatory support specifically for infants and children awaiting heart transplants. EXCOR Pediatric is approved for use in the USA under HDE regulations by the FDA. BFW Inc. 732 Louisville, KY BFW understands the medical profession's demands like no other. With more than 40 years of experience, BFW strives to be a technological pioneer. The company s latest innovations are the next generation of dynamic surgical and examination illumination systems that will revolutionize the global medical community's understanding of lighting solutions. Bio-Gate 436 Buena Park, CA Biomet Microfixation 327 Jacksonville, FL Biomet Microfixation is a leading global health care provider of orthopedic products. The company s thoracic portfolio includes the Pectus Bar for repair of pectus excavatum and the SternaLock Blu Primary Closure System for sternal closure. The Blu System aligns and stabilizes the sternum after sternotomy and enables easier closure after minimally invasive access. Bolton Medical 532 Sunrise, FL Bolton Medical is a subsidiary of the Werfen Life Group. Werfen Life Group is an international company that manufactures and distributes medical diagnostic solutions and medical devices worldwide. Bolton sells endovascular therapies, such as the Relay Thoracic Stent-Graft, in both US and international markets and Relay NBS in international markets. Borgess Health 1028 Kalamazoo, MI Borgess Medical Center is a 424-bed teaching hospital and Level 2 Trauma Center providing nationally recognized cardiac and neurological care with advanced capabilities in multiple specialties. Located in Kalamazoo, MI, Borgess offers a complete continuum of services to 1.1 million people living in 11 counties in southwest and south central Michigan. Buffalo Filter 1134 Lancaster, NY Buffalo Filter is a world-leading medical device manufacturer and supplier of surgical smoke plume evacuation equipment. The company s products are used to evacuate and filter hazardous plume and/or aerosols created during surgical procedures. Buffalo Filter offers one of the most comprehensive and technologically advanced surgical plume evacuation product lines in the world. CardiacAssist, Inc Pittsburgh, PA CardiacAssist's TandemHeart System is a novel percutaneous left ventricle bypass system that can provide up to 5.0 L/min of cardiac output augmentation to patients in need of circulatory support. Unique transseptal cannulation of the left atrium maximizes unloading efficiency before returning oxygenated blood to the femoral artery. CardioPulse 528 Winston-Salem, NC Using instant communication and better technology, CardioPulse coordinates dataflow, interfaces, smart tablets, speech recognition software, interoperability, and intelligent software protocols to facilitate a value-driven environment for analytical research, results reporting, and submission to the STS National Database. Stellar support included! CareFusion 1324 San Diego, CA CareFusion is a global corporation helping clinicians and hospitals measurably improve patient care. The PleurX Catheter System allows patients to manage symptoms associated with recurrent pleural effusions and malignant ascites at home, reducing hospital length of stay and cost of care while improving quality of life. Visit us at booth 1324 to learn more. Carilion Clinic 939 Roanoke, VA Castle Biosciences 326 Greensboro, NC CBSET, Inc Lexington, MA CBSET, Inc. is a not-for-profit preclinical contract research organization dedicated to biomedical research, education, and medical device testing. The company focus is helping companies develop unique tools and new methods to promote early diagnosis and deliver innovative treatments for complex diseases. Chase Medical 1429 Richardson, TX Clear Catheter Systems, Inc Bend, OR CM Creative LLC 1523 Ocean City, MD ConvaTec 437 Solana Beach, CA Cook Medical 938 Bloomington, IN CorMatrix 1121 Roswell, GA CorMatrix Cardiovascular markets its ECM Bioscaffold devices for carotid repair, pericardial repair and reconstruction, and cardiac tissue repair, and is currently conducting preclinical studies to evaluate future applications in other cardiac and vascular applications. Covidien 1211 New Haven, CT Covidien is a leading global health care products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Please visit to learn more. CRC Press/Taylor & Francis Group 317 Boca Raton, FL CRC Press Taylor & Francis Group is a global publisher of world-class references, handbooks, and textbooks for the medical, scientific, and technical communities, including academics, professionals, and students. The company s award-winning CRCnetBASE has its ebook collections. Visit or call (800) or +44 (0) CryoLife 411 Kennesaw, GA CryoLife is a world-leading medical device company providing cardiac lasers for the treatment of refractory angina, preserved human cardiac and vascular tissues, and surgical sealants. CryoLife is committed to partnering with academic training programs and cardiac surgical societies through its new Thoracic Surgery Education Reform Initiative. CTSNet L116 (foyer) Chicago, IL CTSNet (www.ctsnet.org), headquartered in Chicago, is the leading international source of online resources related to cardiothoracic surgery, as well as the major hub of the international online community of cardiothoracic surgeons and allied health care professionals. Dallen Medical Inc. 434 San Clemente, CA Davol Inc. 321 Warwick, RI BARD is the market leader in comprehensive soft tissue reconstruction. In addition to this extensive suite of products, the company s BioSurgery franchise is delivering a growing line of enhanced sealants and hemostatic products to complement surgical techniques across thoracic, cardiovascular, and other surgical specialties. DePuy Synthes CMF 1232 West Chester, PA DePuy Synthes CMF is a global leader in medical devices, offering a comprehensive portfolio of implant systems for surgeons to treat patients who have sustained conditions affecting the face, head, neck, and thorax, including solutions for sternum and rib fixation. DePuy Synthes CMF is part of the DePuy Synthes Companies of Johnson & Johnson. Designs for Vision 1315 Ronkonkoma, NY Just See It with Designs for Vision s lightweight custom-made surgical telescopes now available with Nike frames. See It Even Better with the L.E.D. Daylite, the new UltraMini L.E.D. Daylite, or Twin Beam, providing the brightest and safest untethered illumination. Domain Surgical 1327 Salt Lake City, UT Dornier MedTech America, Inc. 529 Kennesaw, GA Dornier MedTech is committed to providing innovative solutions for a variety of health care fields worldwide and revolutionizes spider and varicose vein treatments by offering multifunctional, state-of-the-art, high performance diode lasers. EBM 1305 Tokyo, Japan EBM, a biomedical spin-out venture company from Japan, provides the original beating Continued on following page
17 STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 TUESDAY/WEDNESDAY ISSUE 17 Continued from previous page heart simulator and quantitative assessment system for OPCAB and vascular anastomosis worldwide. Skill assessment is based on rapid CFD technology and validated silicone vascular model. Edwards Lifesciences 801 Irvine, CA Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring, enabling them to save and enhance lives. Additional company information can be found at Elsevier 1402 Philadelphia, PA Elsevier, a leading publisher of health science publications, advances medicine by delivering superior reference information and decision support tools to doctors, nurses, health practitioners, and students. With an extensive media spectrum print, online, and handheld Elsevier is able to supply the information you need in the most convenient format. Enova Illumination 433 St. Paul, MN Essential Pharmaceuticals 1408 Newtown, PA Essential Pharmaceuticals is a specialty pharmaceutical company devoted solely to the development and sales of exclusive branded pharmaceutical products, including Custodiol HTK organ preservation solution. Custodiol HTK with its easy handling characteristics, water-like viscosity, and no need for additives or filters is the preferred solution for many transplant centers. Estech 621 San Ramon, CA Estech develops and markets a broad portfolio of innovative medical devices and disposables that enable cardiac surgeons worldwide to perform a variety of traditional and minimally invasive surgical procedures. ETHICON 827 Cincinnati, OH The ETHICON brand is used for the products of Ethicon, Inc. and Ethicon Endo-Surgery, Inc., two companies with long histories of medical innovation and which provide globally a broad range of surgical technologies and products (including energy devices, sutures, staplers, clip appliers, trocars, and meshes) used to treat thoracic conditions. European Association for Cardio- Thoracic Surgery (EACTS) L110 (foyer) Windsor, United Kingdom EACTS is the largest European association devoted to the practice of cardiothoracic surgery. The main objectives of the Association are to advance education in the field of cardiothoracic surgery and to promote, for the public benefit, research into cardiovascular and thoracic physiology and therapy and to correlate and disseminate the useful results thereof. Visit the booth for information on membership, future meetings, EACTS Academy, and all other activities of EACTS. European Society of Thoracic Surgeons L120 (foyer) Exeter, UK Fehling Surgical 626 Acworth, GA Fehling Surgical features the CERAMO Instrument Line, SUPERPLAST Probes, and new, innovative retractor systems for minimally invasive cardiac surgery. CERAMO surface means high efficiency through enhanced performance, increased endurance, and minimal maintenance. Figure 8 Surgical 1236 Morgantown, WV Flagship Surgical 1428 Warren, NJ Flagship Surgical provides state-of-the-art surgical matting products designed to promote comfort, manage fluids, and ensure a more ergonomic work environment for those performing surgery: The Surgical Mat, The Mini Mat, and The Suctioner (patented & patent pending). Genesee BioMedical, Inc. 629 Denver, CO Design Beyond Standard. Genesee BioMedical, Inc. provides unique devices for cardiothoracic surgery, including sternal/thoracic valve retractors, instruments for MICS, coronary graft markers, suture guards, retraction clips, and myocardial needles. All products are CE approved. Global Intercepts 315 Dumont, NJ Gore & Associates 421 Flagstaff, AZ The Gore Medical Products Division has provided creative solutions to medical problems for three decades. Over 35 million Gore medical devices have been implanted worldwide. Products include vascular grafts, endovascular and interventional devices, surgical materials, and sutures for use in vascular, cardiac, and general surgery. For more information, visit Hawaiian Moon 429 Clearwater, FL Heart Hugger/General Cardiac 427 San Jose, CA HEART HUGGER is an FDA-classified, Medicare-approved therapeutic medical binder. It is patient operated and provides rigid, encircling support to the entire thorax when the handles are squeezed together. Because it gives uniform encircling support, it works far better than pillows or teddy bears. HEART HUGGER use results in less pain, which means less stress on the wound and a faster return to preop respiratory levels. Patients who manage their own pain are more confident and independent. HeartWare 1201 Framingham, MA The HeartWare Ventricular Assist System, featuring the HVAD Pump, is designed to be implanted in the pericardial space, avoiding the more invasive surgical procedures required with older LVAD technologies. The HVAD Pump is commercially available around the world. HRA Healthcare Research & Analytics 536 Parsippany, NJ HRA is the market leader in conferencebased health care research, with nearly 40 years of experience. The company gathers insights from actively engaged health care professionals using self-administered surveys answering vital marketing and clinical questions that can affect the introduction of new products or the continuation of existing products and services. ImaCor, Inc Garden City, NY ImaCor develops advanced critical care solutions for hemodynamic assessment. htee (hemodynamic TEE) is the first and only technology to provide continuously available direct cardiac visualization. htee is enabled through the 72-hour ClariTEE probe, a miniaturized and disposable TEE probe, and the Zura Imaging Systems, for episodic assessment. International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) L104 (foyer) Beverly, MA ISMICS: innovation, technologies, and techniques in cardiothoracic and cardiovascular/vascular surgery ISMICS Annual Scientific Meeting, May 2014, Marriott Copley Place, Boston, Massachusetts, USA. Intuitive Surgical, Inc Sunnyvale, CA Intuitive Surgical, Inc. designs, manufactures, and distributes the da Vinci Surgical System, technology designed to allow surgeons to perform complex thoracic procedures minimally invasively. JOMDD 1433 Tokyo, Japan Kapp Surgical 832 Cleveland, OH Kapp Surgical is a custom design shop that designs surgical instruments and implants, manufactures them, and sells them, as well as distributes domestically and internationally. Kapp s exclusive products are the Cosgrove Heart Retractor, Strip T s surgical organizer, and countless surgical devices, all FDA-approved with several pending approval. Karl Storz 1029 El Segundo, CA Karl Storz, a leader in endoscopy solutions, offers a range of technologies for thoracic surgery. The company offers solutions for classic and extended mediastinoscopy. Its EN- DOCAMELEON Telescopes allow surgeons to adjust the viewing direction from 0 to 120 throughout procedures. KLS-Martin 728 Jacksonville, FL KLS-Martin, a responsive company, is focused on the development of innovative products for oral, plastic, and craniomaxillofacial surgery. New product developments in the company s titanium osteosynthesis plating systems allow these products to be used for rapid sternal fixation and reconstruction. Koros USA, Inc. 527 Moorpark, CA For the past 30 years, Koros USA, Inc. has been designing and distributing state-of-theart surgical instruments, like the Cervical Black Belt, Lumbar Super Slide, and ALIF Polaris Lateral Retractors, along with the Rotating Osteo Punch, Ejector Punch Rongeurs, and many more fine hand instruments. Lexion Medical 1133 Macon, GA Life Technologies 1437 Foster City, CA LifeNet Health 1033 Virginia Beach, VA LifeNet Health helps save lives and restore health for thousands of patients each year. It is the world s most trusted provider of transplant solutions, from organ procurement to new innovations in bio-implant technologies and cellular therapies a leader in the field of regenerative medicine, while always honoring the donors and health care professionals who allow the healing process. LSI Solutions 1034 Victor, NY COR-KNOT delivers instant security with automated knotting and integrated suture trimming in one easy step. COR-KNOT may reduce cardiopulmonary bypass and cross-clamp time. Internationally recognized innovation for advanced CT surgeons. Visit booth 1034 for more information. MAQUET 813 Wayne, NJ MAQUET Medical Systems is a global leader focused on improving patient care and quality of life. The company offers a comprehensive portfolio of innovative products designed to meet the needs of clinical professionals in the areas of cardiothoracic and vascular surgery, thoracic drainage, cardiac intervention, perfusion, anesthesia, and respiratory. Continued on following page
18 18 TUESDAY/WEDNESDAY ISSUE STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 Continued from previous page Market Access Partners 526 Evergreen, CO Market Access Partners provides market research consulting to the medical device and pharmaceutical industries. It uses innovative qualitative methodologies to research opinions of physicians, nurses, and patients. The company offers a management-oriented approach to product development and marketing. Mayo Clinic 1235 Rochester, MN Mayo Clinic Referring Physician Office 313 Jacksonville, FL Med Alliance Solutions 1226, 1227 St. Charles, IL ISO certified medical device distributor committed to quality and meeting customer and regulatory requirements by providing specialty devices, nationwide representation, superior customer service, and exceptional clinical support. Exclusive distributor of Péters Surgical sutures, Delacroix-Chevalier instrumentation, and Surge Cardiovascular disposables. Medela 521 McHenry, IL Medela, a family-owned business since 1961, has more than 50 years of knowledge-based experience in developing innovative medical vacuum technology. It operates in more than 90 countries, manufacturing more than 1 million medical vacuum devices annually with Swiss quality. Medela has two business units, breastfeeding and health care. Medical Concepts Europe 1132 Buffalo, NY Medistim 721 Plymouth, MN Medistim offers validated technologies that reduce post-cabg major adverse cardiac and cerebrovascular events (MACCE). The VeriQ C provides a novel combination of proven transit time flow assessment along with a new 15 MHz ultrasound probe, specifically designed for epiaortic and epicardial imaging. Medos Medizintechnik AG 428 Heilbronn, Germany Medtronic 601 Minneapolis, MN Find opportunity in change and consider Medtronic s intuitive solutions in structural heart and aortic diseases, including: tissue, mechanical, and transcatheter valves; irrigated RF and cryosurgical ablation devices; aortic stent graft systems; and OPCAB, MICS CABG, cannulae, and perfusion products. MedXpert North America 533 Edmond, OK MedXpert North America, LLC is a producer of medical devices (implants and instruments) specialized for the thoracic part of the human body. The company produces StraTos for three different indications (deformity, reconstruction after tumor resection as well as trauma) and StraCos for one indication (trauma). Mesocare.org 1037 Houston, TX Molnlycke Health Care 1435 Norcross, GA Nadia International 416 Austin, TX Educational/surgical bronze sculptures specifically for the thoracic surgeon. These museum-quality limited editions are created by the world famous sculptor Ronadró. More than 7,000 surgeons in 75 countries collect his fine works of art. His works are on display at the Smithsonian Institute and many medical universities throughout the world. Nationwide Credentialing 435 Granburry, TX Nationwide Credentialing provides physician credentialing and contract management services. The company has over 13 years of experience helping physicians maintain hospital privileges, credentialing, CAQH, and licenses. It provides health care negotiation and follow-up on Medicare and Medicaid applications. Nationwide Credentialing reduces office overhead and saves time and money. ncontact 311 Morrisville, NC ncontact is taking a leadership position in the development of arrhythmia management programs for the health care system. ncontact s mission is to transform the underserved arrhythmia market through a multidisciplinary approach and the advancement of less evasive ablation alternatives. New Wave Surgical 1427 Pompano Beach, FL The Advanced Laparoscopic Care Kit with D- HELP is the only system designed to keep laparoscopic and robotic lenses defogged and clean from start to close! It replaces all other defogging products and cleans, defogs, protects, and heats the scope for 5 hours. It also white balances the scope and is cost effective. Norton Healthcare 837 Louisville, KY Novadaq Technologies 734 Mississauga, Ontario Olympus America, Inc. 715 Center Valley, PA Olympus is a precision technology leader in designing and delivering imaging solutions in health care, life science, and photography. Through its health care solutions, Olympus aims to improve procedural techniques and outcomes, and enhance the quality of life for patients. On-X Life Technologies, Inc. 821 Austin, TX On-X Heart Valves and MV Chordal Repair: Patented natural design and On-X Carbon offer reduced turbulence in a mechanical valve to rival the clinical and hemodynamic performance of bioprostheses. FDA IDE approved PROACT (Prospective Randomized On-X Anticoagulation Clinical Trial) in process. Chord-X eptfe Suture for mitral valve repair available. Oscor Inc Palm Harbor, FL Oxford University Press 414 Cary, NC OUP publishes some of the most respected medical books and journals in the world, including the three journals of the European Association for Cardio-Thoracic Surgery. Visit the booth to browse books and pick up journal sample copies. Pemco Inc. 635 Cleveland, OH Pemco has designed and manufactured precision surgical instruments for the cardiovascular field. The company has documented that perfusion cannula, coronary ostial cannula, and cardiac suckers offer cost savings over disposables. Additional products include reusable subclavian and femoral cannula, anesthesia screens, and the Rultract retractor. Pinnacle Biologics, Inc. 314 Bannockburn, IL Prevea Health 316 Green Bay, WI Prevea Health is the largest physician-led and owned group in Northeastern WI with over 260 providers in 50 specialties. Prevea Health is financially stable with a focus on patient care. Green Bay features abundant recreational and cultural opportunities, nationally rated public and private school systems, a low cost of living, and collegiate, semiprofessional, and professional sports. QED Medical 324 Lexington, KY Since 1971, QED Medical has been a US manufacturer of leading-edge headlight illumination and video systems. Systems include xenon, halogen, LED, fiber optic, and portable systems. Quality, value, and performance in every system. Qualiteam S.r.l Chiaverano, Italy Qualiteam is a company devoted to creating products that will advance postoperative care for patients, thereby improving the overall hospital experience and speeding up recovery, which may result in cost savings for health care administrators. The company presents its products, which are all created with high functionality and a focus on patient comfort. Quest Medical, Inc. 729 Allen, TX Quest Medical, Inc. is a medical device manufacturer and worldwide distributor specializing in protecting the heart during cardiac surgery with the Quest MPS 2 and Microplegia. Quest also offers a unique variety of aortic punches, safety valves, vascular loops, and an anesthesia line designed for optimum cardiovascular surgery. Regional Data Managers: STS National Database L118 (foyer) Ann Arbor, MI The Regional Data Managers booth provides opportunities for surgeons to interact with data managers from around the country who are actively involved with regional STS National Database efforts and collaborative STS groups. Come learn about regional activities and initiatives! Rocket Medical 1420 Hingham, MA Rose Micro Solutions 737 West Seneca, NY RTI Surgical 1401 Marquette, MI RTI Surgical proudly offers Tritium SCP, an FDA-cleared sternal cable plating system. Tritium addresses varying patient anatomies, providing surgeons with more options. RTI is a leading designer and manufacturer of implants and instruments used for chest closures following median sternotomies. Rultract 633 Cleveland, OH Rultract s surgical retractor provides gentle and uniform lift, allowing maximum exposure for IMA dissection, redo hearts, xiphoid entry, subxiphoid pericardial procedures, minimally invasive procedures (Thoratrak capable), parasternal procedures, pediatric/asd, t-incisions, transabdominal GEA midcab, pectus, LVAD extraction, and TEMLA procedures. Sanofi Biosurgery 410 Cambridge, MA Sanofi Biosurgery develops and markets innovative, biologically based products for osteoarthritis relief, adhesion prevention, temporary endovascular occlusion of blood vessels, cartilage repair, and severe burn treatment. Sanofi Biosurgery is committed to transforming disease management through innovative medical interventions. Scanlan International 300 St. Paul, MN Highest quality surgical products designed and manufactured by the Scanlan family since More than 3,000 surgical instruments in titanium and stainless steel, including D'Amico Mediastinoscopy Biopsy Forceps, new shorter VATS instruments, Uniportal VATS instruments, MEMORY Dilators/Vessel Probes, LEGACY Needle Holders and Forceps, and single-use products. Continued on following page
19 STS 50TH ANNUAL MEETING JANUARY 25-29, 2014 TUESDAY/WEDNESDAY ISSUE 19 Continued from previous page Smith & Nephew 432 St. Petersburg, FL Society for Heart Valve Disease, The L106 Beverly, MA SHVD is an organization composed of cardiologists, cardiothoracic surgeons, basic scientists, allied health professionals, and students, formed to undertake, promote, support, and encourage research and public education regarding the causes, prevention, and treatment of heart valve disease. The Society holds biennial meetings with the Heart Valve Society of America. Society of Thoracic Surgeons, The STS Pavilion (Central Atrium) Chicago, IL The Society of Thoracic Surgeons represents more than 6,800 surgeons, researchers, and allied health care professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus, as well as other surgical procedures within the chest. The Society offers a wide variety of member benefits, including reduced participation fees in the world renowned STS National Database, a complimentary subscription to The Annals of Thoracic Surgery, dynamic educational offerings, online patient information resources, and much more. The Society also supports cutting-edge research via the STS Research Center and advocates in Washington, DC, on behalf of cardiothoracic surgery professionals and their patients. Stop by the STS Pavilion, located in the Central Atrium, or visit to learn more. Somahlution 1137 Jupiter, FL Somahlution is a privately-held developmentstage life science company focused on advancing the science of organ and surgical conduit transplantation. Led by a highly experienced team of executives, transplant researchers, and surgeons, our products and technologies have the potential to profoundly impact the landscape of transplant medicine. Sontec Instruments 1301 Centennial, CO Sontec offers headlights, loupes, and the most comprehensive selection of exceptional handheld surgical instruments available to the discriminating surgeon. There is no substitute for quality, expertise, and individualized service. Sontec s vast array awaits your consideration at its booth. Sorin Group 1001 Arvada, CO Spiration, Inc. 927 Redmond, WA Spiration is committed to improving quality of life for patients with acute and chronic conditions of the lung through the development of novel therapies. The IBV Valve System has FDA approval under humanitarian use to control specific prolonged postoperative air leaks. St. Jude Medical 401 St. Paul, MN St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world s most expensive, epidemic diseases. The company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, MN, St. Jude Medical has four major clinical focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular, and neuromodulation. Please visit sjm.com. Stellar Technologies 312 Brooklyn Park, MN Stellar Technologies is an ISO 9001 and certified FDA-compliant designer, developer, and manufacturer of medical components, devices, and electromechanical assemblies. The company specializes in single-use disposable devices, neuro and cardiac lead assemblies, device delivery systems, endoscopic and ablation assemblies, complex components and assemblies, and laser-cut and welded assemblies. Sunoptic Technologies 1130 Jacksonville, FL Sunoptics Surgical offers a premium line of TITAN and Solar branded surgical headlights, fiberoptic and battery-operated LED, light sources, video cameras, recording devices, fiberoptic cables, and accessories. Sunoptics Surgical delivers outstanding market-oriented products combining high quality with exclusive distribution and worldwide support. superdimension 1120 Minneapolis, MN SurgiTel 426 Ann Arbor, MI SurgiTel s mission is to offer customers the best in vision, comfort, and ergonomics. The company s patented lightweight optics and LEDs, coupled with Oakley frames, means all-day comfort for the clinician. SurgiTel s unmatched loupe declination angle means your body is in the correct ergonomic position, reducing pain and the risk of injury. Its loupe-mounted SurgiCam Pro digital video camera and PrismPro loupe line (5.5x-8.0x) can only be seen at SurgiTel. SynCardia Systems, Inc. 835 Tucson, AZ The SynCardia temporary Total Artificial Heart (TAH-t) is the world s only FDA, Health Canada, and CE approved Total Artificial Heart. It is approved as a bridge to transplant for patients dying from end-stage biventricular failure. Visit the SynCardia booth for updates on the 50cc TAH-t and destination therapy. Teleflex 1321 Durham, NC Teleflex offers today s cardiothoracic surgeon comprehensive resources, including the Horizon Ligation System, Hemoclip Ligation, Hem-o-lok Ligation System, Tevdek Suture, Deklene Maxx Suture, and Pleur-evac Chest Drainage. The Weck, Deknatel, and Pilling brands are recognized for providing cardiovascular products that enhance patient outcomes. TEM Systems, Inc. 637 Durham, NC Tenaxis Medical, Inc. 836 Mountain View, CA Tenaxis Medical, Inc. develops and commercializes high-performance sealants and antiadhesion agents for use in vascular and general surgery. The company is dedicated to developing surgical sealants based on input from various surgical specialties. ArterX Surgical Sealant is now available in the United States and throughout most of Europe. Terumo 301 Ann Arbor, MI The Medicines Company 1416 Parsippany, NJ The Medicines Company is a global biopharmaceutical company focused on saving lives, alleviating suffering, and improving the economic efficiency of the leading acute and intensive care hospitals in the world. It aims to be a leading provider of solutions and knowledge to improve health outcomes in these hospitals. The VAD Consulting Group 936 Spokane, WA Whether your VAD program is just starting out or you are an established center looking to increase financial and operational efficiencies, the VAD Consulting Group has the experience and expertise to help you in today s challenging environment. Thompson Surgical 934 Traverse City, MI Thompson Surgical celebrates 50 years as the world s best retractor. Cardiovascular surgeons will benefit from the Thompson Surgical Bolling Retractor, which provides low profile, stable, uncompromised exposure of the heart structures. The company provides innovative, high-quality systems that deliver safe, versatile retraction. Thoracic Surgery Foundation for Research and Education (TSFRE) L (foyer) Chicago, IL TSFRE was established in 1988 as a 501c(3) not-for-profit charitable organization by the four leading thoracic surgery societies: AATS, STS, STSA, and WTSA. TSFRE s mission is to foster the development of surgeon scientists in cardiothoracic surgery, increasing knowledge and innovation to benefit patient care. Thoramet Surgical 1128 Rutherford, NJ VATS instruments! Thoramet Surgical Products sells the most complete line of VATS instruments available. Produced in the USA in their own facilities, they are the surgeon's choice. Come to booth 1128 to see their unique versatility. Thoramet has the feel you want, the actuation you need, and the patterns you demand! Thoratec Corporation 1013 Pleasanton, CA Thoratec is the world leader in mechanical circulatory support with the broadest product portfolio to treat the full range of clinical needs for patients suffering from advanced heart failure. Thoratec s products include the HeartMate LVAS, Thoratec VAD, CentriMag, and PediMag / PediVAS. Transonic 328 Ithaca, NY Transonic s AureFlo Surgical-QA System is used during surgery with Transonic s signature Perivascular Flowprobes and the new and improved Optima Flow-QC meter to measure, display, capture, and document absolute volume flow in vessels. Obtain peace of mind by measuring blood flow just prior to approximation with Transonic flow measurement. University of Tennessee Physician Executive MBA Program 1417 Knoxville, TN The #1 preferred Physician Executive MBA at The University of Tennessee is an internationally accredited 1-year-long MBA delivered via distance education and campus residency periods, offered exclusively for physicians seeking leadership skills. Vitalcor, Inc./Applied Fiberoptics 828 Westmont, IL Vitalitec Geister 921 Plymouth, MA Vitalitec Geister will be displaying all company products highlighting the Enclose II Anastomosis Assist Device, Cygnet Flexible Clamps, Intrack Atraumatic Temporary Clamps and Inserts, and Geister ValveGate and ValveGate PRO line of minimally invasive cardiovascular instrumentation. Wexler Surgical 1309 Houston, TX Wexler Surgical designs and manufactures a variety of titanium and stainless steel specialty surgical instruments and products for cardiac, vascular, thoracic, and microsurgery. Come see the company s VATS/MICS instruments and ask about the Optimus Series. Visit Wexler online at for more information about its products and services. Wolters Kluwer 1521 St. Cloud, FL World Society for Pediatric and Congenital Heart Surgery 937 Montreal, Canada The mission of the World Society for Pediatric and Congenital Heart Surgery is to promote the highest quality comprehensive cardiac care to all patients with congenital heart disease, from the fetus to the adult, regardless of the patient s economic means, with an emphasis on excellence in teaching, research, and community service.
20 sorin group Cardiac Surgery Solutions EQUIPPED TO PERFORM Sorin Group has developed a complete range of innovative solutions designed for patients with heart disease. Working alongside leading physicians worldwide we provide advanced therapies that restore patient health allowing them to return to their lifestyle. HEARTLINK SYSTEM A full range of aortic and mitral valve replacement and repair solutions providing long-term clinical outcomes The Mitroflow Aortic Pericardial Heart Valve with 30 years of durability and hemodynamic performance Cannulae designed to satisfy all clinical and procedural needs including conventional, optimized and MICS The NEW Sorin HeartLink integrated perfusion system the most advanced system on the market today SORIN S5 HEART LUNG MACHINE INSPIRE TM MITROFLOW CANNULAE Advanced Patient Care 2014 Sorin Group Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. Trademark used herein are owned by or licensed to Sorin Group USA, Inc.